KospicyKorean filings in English
Filings / L&C BIO

Beneficial Ownership Report (5%) — Standard Form

L&C BIO · 주식등의대량보유상황보고서(일반)

SC 13D/GKOSDAQ · 290650 Filed 2026-11-17Korean original on DART

English form view 71% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Report on large shareholdings (general)

6.1

주식회사 엘앤씨바이오

1100

0100

Report on Large Holdings of Shares, etc.

(General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control)
To: Financial Services CommissionReporting obligation date:2026-11-12
To: Korea ExchangeReport reference date:2026-11-17
Reporting person:이 환 철
Summary
Issuer name주식회사 엘앤씨바이오Relationship to IssuerLargest Shareholder
Report Type변동ㆍ변경
Number of Shares Held and Holding RatioNumber of Shares HeldHolding Ratio
Previous Report12,584,44420.59
Current Report12,708,50420.80
Shares under key agreements: number and ratioNumber of shares, etc.Ratio
Previous Report1,900,0003.11
Current Report3,800,0006.22
Number of voting rights and holding ratioNumber of Voting RightsHolding Ratio
Previous Report--
Current Report--
Voting rights under key agreements: number and ratioNumber of Voting RightsRatio
Previous Report--
Current Report--
Reason for Report무상증자에 따른 주식매수선택권 수량변동 및 계약사항 변경
※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission.

Part 1 Report Overview

1. Issuer information

Company Name주식회사 엘앤씨바이오Company code290650
Entity typeKOSDAQ-Listed CompanyTotal Issued Voting Shares (shares)61,107,168

2. Major shareholder information

a. Reporting person

(1) Reporting person overview

Report Type변동ㆍ변경Joint signatories
Reporting person typeIndividual (Domestic)NationalityRepublic of Korea
Basis for Reporter Classification (only if reported as a statutory partnership or other entity)-
Name (Entity Name)Korean이환철Chinese characters (English)李煥鐵(Lee whan-chul)
Address (Head Office) [Town/District Level Only]서울특별시 서초구 고무래로Date of Birth or Business Registration No., etc.760315
Occupation (business)ExecutiveRelationship to IssuerLargest Shareholder
Business contact and person in chargeAffiliated company주식회사 엘앤씨바이오Department경영관리팀
PositionManagerPhone Number070-77***
Name이종찬Fax number02-541*
Email address**@lncbio.co.kr

(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)

Legal form-
Total Assets (or Total Assets Under Management)-Total Liabilities-
Total Equity-Paid-in Capital-
Representative (representative or managing partner)-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Largest Investor)-Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)-

b. Specially related parties

(1) Specially related party overview

No.NameCategorySpecific Relationship to ReporterDate of Birth or Business Registration No., etc.NationalityAddress (Location)Occupation (Business)Relationship to Issuer
1황일선Individual (Domestic)Relatives790301Republic of Korea서울시 성동구 고산자로-Shareholder
2이미선Individual (Domestic)Relatives570724Republic of Korea경기도 수원시 영통구 영통로-Shareholder
3조건희Individual (Domestic)Relatives740309Republic of Korea경기도 양주시 삼숭로-Shareholder
4이지한Individual (Domestic)Relatives071020Republic of Korea서울시 서초구 고무래로-Shareholder
5이지성Individual (Domestic)Relatives110201Republic of Korea서울시 서초구 고무래로-Shareholder
6이재호Individual (Domestic)Executive750504Republic of Korea서울시 강남구 광평로주식회사 엘앤씨바이오 등기임원Executive officers (registered)
7신성훈Individual (Domestic)Officer of Affiliate780220Republic of Korea부산시 해운대구 재송동계열회사 등기임원Officers of affiliates, etc.
8김창수Individual (Domestic)Officer of Affiliate730211Republic of Korea경기도 용인시 기흥구 마북로계열회사 등기임원Officers of affiliates, etc.
9손석우Individual (Domestic)Officer of Affiliate771008Republic of Korea경기도 구리시 갈매동계열회사 등기임원Officers of affiliates, etc.
10(주)글로벌의학연구센터Domestic corporationAffiliate765-88-00920Republic of Korea서울특별시 서초구 나루터로화장품 CRO, 의학 및 약학 연구개발Affiliates, etc.
11엘앤씨바이오 사내근로복지기금기타단체(국내)Other218-82-02022Republic of Korea경기도 성남시 중원구 둔촌대로사내근로복지기금Other
* Address to town/district level only

(2) 특별관계자에 대한 구체적인 사항(법인, 기타단체, 법령상조합, 민법상 조합의 경우 기재)① (주)글로벌의학연구센터

(Record Date:2025-12-31)(Unit: KRW thousand)
Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)36,151,768Total Liabilities13,710,545
Total Equity22,441,224Paid-in Capital1,666,023
Representative (representative or managing partner)임두현
Decision-Making Body (Decision Maker)이사회 및 주주총회
Largest Shareholder (Largest Investor)주식회사엘앤씨바이오Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)48.30

② 엘앤씨바이오사내근로복지기금

(Record Date:2025-12-31)(Unit: KRW thousand)
Legal form사내근로복지기금
Total Assets (or Total Assets Under Management)6,807,042Total Liabilities5,586,150
Total Equity1,220,892Paid-in Capital1,220,892
Representative (representative or managing partner)이환철
Decision-Making Body (Decision Maker)복지기금협의회
Largest Shareholder (Largest Investor)-Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)-

c. Collective investment manager

(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))

(1) Collective investment manager overview

No.NameBusiness Registration No., etc.Target collective investment vehicleNationalityAddress (Location)Remarks
-------

3. Shares, etc. held and holding ratio

Report reference dateReporting personShares, etc.Share CertificatesTotal Issued Voting Shares (shares)
Name of HolderNumber of Specially Related PersonsNumber of Shares, etc. (shares)Ratio (%)Number of Shares (shares)Ratio (%)
Previous Report2026-10-30이환철1112,584,44420.5912,459,44420.3961,107,168
This Report2026-11-17이환철1112,708,50420.8012,459,44420.3961,107,168
Change124,0600.21-0.000

4. Purpose of holding

Impact on management control
본인은 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각 호의 사항에 대하여 회사의 최대주주로서 영향력을 행사하고자 합니다. 회사의 업무집행과 관련한 각 호의사항이 발생할 경우에는 회사의 경영목적에 부합하도록 관련 행위들을 결정할 예정입니다.- 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각 호(아래1~9호)1. 이사 및 감사의 선임.해임 또는 직무의 정지2. 이사회 등 회사의 기관과 관련된 정관의 변경3. 회사의 자본금의 변경4. 회사의 합병,분할과 분할합병5. 주식의 포괄적 교환과 이전6. 영업전부의 양수.양도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수,양도7. 자산의 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분8. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익전부를 같이하는 계약,그 밖에 이에 준하는 계약의 체결,변경 또는 해약9. 회사의 해산

5. Reason for change

Method of change무상증자에 따른 주식매수선택권 조정
Reason for change무상증자에 따른 보유주식등의 내역 변동
Reason for Change무상증자에 따른 주식담보대출 담보수량 변경

Part 2 Details of Large Holdings

1. Holdings by reporting person and specially related persons

A. Holdings by type of shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Shares Held
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person이환철76031511,856,044--------11,856,04419.40
Specially Related Party황일선79030152,000--------52,0000.09
이미선57072472,000--------72,0000.12
조건희74030962,000--------62,0000.10
이지한07102016,640--------16,6400.03
이지성11020116,640--------16,6400.03
이재호750504--------199,250199,2500.33
신성훈78022035,892-------9,96245,8540.08
김창수730211--------39,84839,8480.07
손석우7710088,436--------8,4360.01
(주)글로벌의학연구센터765-88-0092039,536--------39,5360.06
엘앤씨바이오사내근로복지기금218-82-02022300,256--------300,2560.49
Aa1a2BCDEFG
H
Total Issued Voting Shares (I)Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H)Holding Ratio (%)
Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100Share Holding Ratio (A / I) × 100
61,107,168249,06020.8020.39

※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares

B. Holdings by form of holding

RelationshipName (Entity Name)Date of Birth or Business Registration No., etc.Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act)Total
No. 1No. 2No. 3No. 4No. 5No. 6No. 7Number of sharesRatio
Reporting person이환철76031511,856,044------11,856,04419.40
Specially Related Party황일선79030152,000------52,0000.09
이미선57072472,000------72,0000.12
조건희74030962,000------62,0000.10
이지한07102016,640------16,6400.03
이지성11020116,640------16,6400.03
이재호750504------199,250199,2500.33
신성훈78022035,892-----9,96245,8540.08
김창수730211------39,84839,8480.07
손석우7710088,436------8,4360.01
(주)글로벌의학연구센터765-88-0092039,536------39,5360.06
엘앤씨바이오 사내근로복지기금218-82-02022300,256------300,2560.49
※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them

2. Contracts on shares held

A. Contract status

Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.)
Yes

*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported

B. Contract details

No.Name (Entity Name)Relationship to ReporterDate of Birth or Business Registration No., etc.Type of shares, etc.Number of shares, etc.CounterpartyContract typeContract date (amendment date)Contract periodRatioRemarks
1이환철Self760315Voting Shares3,800,000한국증권금융담보계약2026-11-122019.10.28 ~ 2027.04.28(1회차)2023.04.14 ~ 2027.04.14(3회차)6.22Stock-Backed Loan
Total (number of shares, etc.)3,800,000Total (ratio)6.22-

C. Additional details if the main contract is a security agreement

No.Number of shares, etc.Loan amountDebtorInterest rateCollateral maintenance ratioOther
13,800,00017,000,000,000이환철5.44110-

3. Holdings by proprietary and customer account (financial institutions only)

NameRelationship to ReporterBy accountTotal
Own Account (shares)Ratio (%)Customer account (shares)Ratio (%)Total (shares)Ratio (%)
--------
Total------

Part 3 Material Changes Since Last Report Date

1. Summary of changes

a. Changes in shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Changes in Shares, etc.
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person이환철760315-----------
Specially Related Party황일선790301-----------
이미선570724-----------
조건희740309-----------
이지한071020-----------
이지성110201-----------
이재호750504--------99,25099,2500.17
신성훈780220--------4,9624,9620.01
김창수730211--------19,84819,8480.04
손석우771008-----------
(주)글로벌의학연구센터765-88-00920-----------
엘앤씨바이오 사내근로복지기금218-82-02022-----------

2. Change details

a. Detailed changes in shares, etc.

(Unit: shares, KRW)
Name (Entity Name)Date of Birth or Business Registration No., etc.Change Date*Acquisition/disposal methodType of shares, etc.Change detailsAcquisition/disposal unit price**Remarks
Before ChangeChangeAfter Change
이재호7505042026-11-09기타(+)Other100,00099,250199,250--무상증자에 의한 주식매수선택권 조정
신성훈7802202026-11-09기타(+)Other5,0004,9629,962--무상증자에 의한 주식매수선택권 조정
김창수7302112026-11-09기타(+)Other20,00019,84839,848--무상증자에 의한 주식매수선택권 조정

* For trades on the securities market, the contract date

** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities

3. Source of acquisition funds

(1) Overview of acquisition funds

(Unit: KRW)
NameDate of birth or business registration no., etc.Own funds (H)Borrowings (I)Other (J)Total (H+I+J)
이재호750504--99,25099,250
신성훈780220--4,9624,962
김창수730211--19,84819,848

주) '기타(J)'는 무상증자에 따른 주식매수선택권 조정수량을 기재하였습니다.

(2) Origin and source of acquisition funds

ㅇ 기타의 경우

NameDate of birth or business registration no., etc.Source and Formation of Acquisition Funds
이재호750504무상증자에 의한 주식매수선택권 조정
신성훈780220무상증자에 의한 주식매수선택권 조정
김창수730211무상증자에 의한 주식매수선택권 조정